cbdMD, Inc.YCBDNYSE
Loading
Operating Income Growth AcceleratingAccelerating
Percentile Rank79
5Y CAGR-1.0%
Year-over-Year Change
Year-over-year operating income growth rate
5Y CAGR
-1.0%/yr
Long-term compound
Percentile
P79
Within normal range
vs 5Y Ago
1x
Modest growth
Streak
3 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 58.26% |
| Q3 2025 | 24.19% |
| Q2 2025 | -86.22% |
| Q1 2025 | -463.12% |
| Q4 2024 | 65.35% |
| Q3 2024 | 34.83% |
| Q2 2024 | 74.41% |
| Q1 2024 | -49.54% |
| Q4 2023 | 50.04% |
| Q3 2023 | -9.56% |
| Q2 2023 | -30.20% |
| Q1 2023 | 65.38% |
| Q4 2022 | -35.45% |
| Q3 2022 | -27.10% |
| Q2 2022 | 53.09% |
| Q1 2022 | 28.03% |
| Q4 2021 | 0.73% |
| Q3 2021 | -5.05% |
| Q2 2021 | -60.17% |
| Q1 2021 | -136.81% |
| Q4 2020 | 61.16% |
| Q3 2020 | -238.77% |
| Q2 2020 | 76.78% |
| Q1 2020 | 5.76% |
| Q4 2019 | -20.77% |
| Q3 2019 | 21.73% |
| Q2 2019 | -218.93% |
| Q1 2019 | -85.74% |
| Q4 2018 | -20.98% |
| Q3 2018 | -243.80% |
| Q2 2018 | -61.27% |
| Q1 2018 | 231.92% |
| Q4 2017 | -345.68% |
| Q3 2017 | -141.01% |
| Q2 2017 | 1026.80% |
| Q1 2017 | 87.13% |
| Q4 2016 | 45.31% |
| Q3 2016 | 27.57% |
| Q2 2016 | 0.00% |